| Current Price | $161.98 | Mkt Cap | $426.6B |
|---|---|---|---|
| Open | $163.27 | P/E Ratio | 28.21 |
| Prev. Close | $161.98 | Div. (Yield) | $4.24 (2.6%) |
| Daily Range | $161.79 - $164.19 | Volume | 12,993,018 |
| 52-Wk Range | $133.65 - $173.65 | Avg. Daily Vol. | 6,835,997 |
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
| Current Price | $161.98 | Mkt Cap | $426.6B |
|---|---|---|---|
| Open | $163.27 | P/E Ratio | 28.21 |
| Prev. Close | $161.98 | Div. (Yield) | $4.24 (2.6%) |
| Daily Range | $161.79 - $164.19 | Volume | 12,993,018 |
| 52-Wk Range | $133.65 - $173.65 | Avg. Daily Vol. | 6,835,997 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividends500 tracks the healthiest dividends in the S&P 500.To qualify for the portfolio, the company must meet three simple requirements:- Member of the S&P 500- Payout ratio below 50%- Dividend growth year over year
Read the most recent pitches from players about JNJ.
Recs
TMFAdriaCimino
(32.84)
Submitted: 1/14/2021 8:50:20 AM :
Start Price:
$159.46
NYSE:JNJ Score:
-7.44
J&J has a strong revenue and profit track record -- and a vast product portfolio. So I expect it to win over the long term.
Recs
naseerkhan
(25.70)
Submitted: 1/14/2021 12:16:42 AM :
Start Price:
$159.46
NYSE:JNJ Score:
-7.44
COVID-19 vaccine finally showing good results
Recs
kewpiepoo
(22.72)
Submitted: 1/7/2021 12:36:46 PM :
Start Price:
$159.27
NYSE:JNJ Score:
-7.91
- tons of optionality
- COVID19 Vaccine looks promising
- have patented a lot of hard-to-manufacture drugs
- diverse healthcare segments including auto-surgical equipment
- slow and steady growth
Find the members with the highest scoring picks in JNJ.
juliojulio (< 20) Score: +138.13
The Score Leader is the player with the highest score across all their picks in JNJ.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| juliojulio | < 20 |
|
|
1Y | $39.14 | +313.84% | +451.97% | +138.13 | 0 Comment | |
| jokester2222 | < 20 | 2/19/2009 |
|
3W | $38.68 | +318.80% | +437.23% | +118.43 | 0 Comment | |
| Nonnah | 39.74 | 2/19/2009 |
|
3W | $38.99 | +315.45% | +429.35% | +113.90 | 0 Comment | |
| erkleiner | < 20 | 11/24/2008 |
|
NS | $40.75 | +297.51% | +407.91% | +110.41 | 0 Comment | |
| bullear1 | 52.72 | 7/24/2007 |
|
3Y | $40.96 | +295.50% | +185.25% | +110.25 | 0 Comment | |
| jbarnes1217 | 89.93 | 7/24/2007 |
|
3Y | $40.96 | +295.50% | +185.25% | +110.25 | 0 Comment | |
| paladin65 | < 20 | 7/24/2007 |
|
1Y | $40.96 | +295.50% | +185.25% | +110.25 | 1 Comment | |
| cando123 | < 20 | 7/24/2007 |
|
5Y | $40.96 | +295.50% | +185.25% | +110.25 | 0 Comment | |
| GreedyMo | < 20 |
|
|
5Y | $40.96 | +295.50% | +185.25% | +110.25 | 0 Comment | |
| fartalope | < 20 | 7/24/2007 |
|
5Y | $40.96 | +295.50% | +185.25% | +110.25 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
